Skip to main content
. 2022 Jun 15;177:68–80. doi: 10.1016/j.ejpb.2022.06.004

Fig. 12.

Fig. 12

OVA-specific CTL activity after transcutaneous immunization with immunoliposomes and MN was evaluated by using E.G7-OVA cells (A) or EL4 cells (B) as targets. The data were presented as means ± sd (n = 6), *P<0.05, **P<0.01, ***P<0.001.